Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (181-190 of 313) with videos related to

Pageof 32
Sort By:
European Journal of Haematology|May 14, 2026
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted TherapyEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Genes, Chromosomes & Cancer|June 4, 2008
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Katia Todoerti, et al.
Journal of Medical Virology|March 30, 2021
Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 ageOrnella Spagnolello, Alessandra Pierangeli, Maria Civita Cedrone, et al.
Expert Opinion on Investigational Drugs|March 9, 2011
Epigenetic regulation in myelodysplastic syndromes: implications for therapyErnesto Vigna, Anna Grazia Recchia, Antonio Madeo, et al.
Non-Coding RNA|March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical OutcomeDomenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Leukemia & Lymphoma|July 22, 2016
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II studySamantha Pozzi, Massimo Gentile, Stefano Sacchi, et al.
Hematological Oncology|October 22, 2021
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cellsSerena Matis, Martina Rossi, Lorenzo Brondolo, et al.
Blood|October 15, 2011
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemiaFortunato Morabito, Rosaria De Filippi, Luca Laurenti, et al.
BMC Medical Genomics|September 6, 2013
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemiaDomenica Ronchetti, Laura Mosca, Giovanna Cutrona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2010
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletionLaura Mosca, Sonia Fabris, Marta Lionetti, et al.
Pageof 32

Showing results (181-190 of 313) with videos related to

Sort By:
Pageof 32
European Journal of Haematology|May 14, 2026
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted TherapyEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Genes, Chromosomes & Cancer|June 4, 2008
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Katia Todoerti, et al.
Journal of Medical Virology|March 30, 2021
Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 ageOrnella Spagnolello, Alessandra Pierangeli, Maria Civita Cedrone, et al.
Expert Opinion on Investigational Drugs|March 9, 2011
Epigenetic regulation in myelodysplastic syndromes: implications for therapyErnesto Vigna, Anna Grazia Recchia, Antonio Madeo, et al.
Non-Coding RNA|March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical OutcomeDomenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Leukemia & Lymphoma|July 22, 2016
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II studySamantha Pozzi, Massimo Gentile, Stefano Sacchi, et al.
Hematological Oncology|October 22, 2021
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cellsSerena Matis, Martina Rossi, Lorenzo Brondolo, et al.
Blood|October 15, 2011
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemiaFortunato Morabito, Rosaria De Filippi, Luca Laurenti, et al.
BMC Medical Genomics|September 6, 2013
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemiaDomenica Ronchetti, Laura Mosca, Giovanna Cutrona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2010
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletionLaura Mosca, Sonia Fabris, Marta Lionetti, et al.
Pageof 32